OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption

OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption

Bibliographic Details
Main Authors:	H. King, D. Brammer, C. Lehman, M. Roederer, D. Bolton, R. Mason, K. Song, K. Foulds, J. Lifson, P. Darrah, R. Geleziunas
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022002163

Similar Items

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.
by: Taina T Immonen, et al.
Published: (2021-06-01)

Fingolimod treatment at ART initiation delays SIV rebound after ART interruption
by: M. Pino, et al.
Published: (2019-07-01)

Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques
by: M. Paiardini, et al.
Published: (2015-12-01)

Models of SIV rebound after treatment interruption that involve multiple reactivation events.
by: Christiaan H van Dorp, et al.
Published: (2020-10-01)

Predictors of SIV recrudescence following antiretroviral treatment interruption
by: Mykola Pinkevych, et al.
Published: (2019-10-01)

Single-cell transcriptome of in vivo SIV-infected rhesus macaque CD4 T cells
by: A. Tokarev, et al.
Published: (2019-12-01)

Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017-12-01)

Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
by: William Schreiber-Stainthorp, et al.
Published: (2018-07-01)

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
by: Christine M Fennessey, et al.
Published: (2017-05-01)

Clones of SIV-infected cells are present in spleen and lymph nodes in rhesus macaques
by: S.H. Hughes, et al.
Published: (2015-12-01)

SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-<i>Mycobacterium tuberculosis</i> Co-Infection
by: Kaho H. Tisthammer, et al.
Published: (2021-12-01)

OA4-1 Combined IL-21 and IFNα treatment limits residual inflammation, viral persistence and delays viral rebound in SIV-infected rhesus macaques
by: L. Micci, et al.
Published: (2017-07-01)

Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV‐Infected Macaques
by: Qing Yang, et al.
Published: (2019-07-01)

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
by: Brandon F Keele, et al.
Published: (2024-04-01)

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir
by: Brandon F. Keele, et al.
Published: (2024-04-01)

Acute infection by SIV: massive immunological damage
by: Roederer Mario
Published: (2006-12-01)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
by: Hamimi C, et al.
Published: (2012-09-01)

Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism
by: Joseph Antony
Published: (2019-12-01)

Increased neutrophil apoptosis in chronically SIV-infected macaques
by: Gougerot-Pocidalo Marie-Anne, et al.
Published: (2009-03-01)

Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques.
by: Emily R Roberts, et al.
Published: (2016-12-01)

Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
by: Daniel Mendoza, et al.
Published: (2013-02-01)

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques
by: M. Mavigner, et al.
Published: (2016-07-01)

Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.
by: Chie Sugimoto, et al.
Published: (2010-01-01)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
by: Jensen K, et al.
Published: (2012-09-01)

Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.
by: Eugene V Barsov, et al.
Published: (2011-01-01)

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
by: Hugh C Welles, et al.
Published: (2018-12-01)

Rhesus macaque IFITM3 gene polymorphisms and SIV infection.
by: Michael Winkler, et al.
Published: (2017-01-01)

IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
by: Garibal Julie, et al.
Published: (2012-09-01)

Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques
by: Y. Wu, et al.
Published: (2017-12-01)

Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques
by: Nichole R. Klatt, et al.
Published: (2021-03-01)

Correction: Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8+ T Cells Conveys the Ability to Suppress SIV Replication.
by: Eugene V Barsov, et al.
Published: (2018-01-01)

Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.
by: Shruthi Ravimohan, et al.
Published: (2012-01-01)

Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques.
by: Aidin Tavakoli-Tameh, et al.
Published: (2020-04-01)

Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
by: Konstantin Virnik, et al.
Published: (2020-01-01)

Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.
by: Deborah Heydenburg Fuller, et al.
Published: (2012-01-01)

Correction: Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity
Published: (2013-01-01)

P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
by: Van Rompay K, et al.
Published: (2009-10-01)

Correction: Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity.
by: Shruthi Ravimohan, et al.
Published: (2013-01-01)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
by: Ping Zhang
Published: (2023-01-01)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
by: Archana V. Boopathy, et al.
Published: (2023-11-01)